Read the latest news & information concerning Hydrocodone. FRIDAY, June 30, 2017 – One in five people who gets commercial health insurance from Blue.
Nearly half of the prescriptions (47 percent) were handwritten, and 89 percent of these did not meet "best practice" guidelines or were missing at least two forms of patient identification information. Read more. WEDNESDAY, July 12, 2017 – Mistakes are much more likely to occur with handwritten prescriptions for opioid painkillers than with electronic ones, a new study finds. None of the prescriptions produced by the hospital's electronic prescribing system had either of these errors.
DEA Administrative Decisions Update: Has DEA Established New Grounds for 18669 (Apr. 20, 2017), holds that an allegation of material.
§ 1301.74(b). The language in that section has remained unchanged since its enactment in 1971 and while DEA issued informal guidance letters to certain industry groups in 2006, 2007 and 2012, DEA’s interpretation of that regulation has evolved significantly beyond that guidance. More important, a fundamental deficiency in the regulation is that it fails to recognize the differences between manufacturers and distributors, including the level of data available to each concerning sales between distributors and pharmacies. Thus, the lack of a clear regulation has continued to hinder industry’s ability to meet DEA’s expectations.
Updated on January 11, 2017 at 7:11 PM Posted on January 11, 2017 at 5:44 PM Chris Christie's plan to prevent doctors in New Jersey from writing his office has the power to submit emergency regulations limiting opioid.
State Attorney General Christopher Porrino told NJ Advance Media his office would likely be submitting new rules based on the governor's recommendation to state regulators by the end of the month.
The 30-day prescription, Christie said, "is dangerous, ill-advised and absoluy unnecessary. We must work against potential addiction -- and overdose -- by limiting supply to five days that can be obtained at the outset of treatment.".
John Kasich on Thursday announced new limits for prescribing Updated on June 5, 2017 at 12:50 PM Posted on March 30, 2017 at 11:45 AM not through legislation, as allowed by a new law that takes effect next week.
The legislative plan provides the same exemptions for certain patients, but differs in several ways:
The acute pain prescribing limits is the latest step in the state's effort to fight the opioid crisis. Ohio led the nation in opioid overdose deaths in 2014, and deaths have continued to rise with increased use of heroin and fentanyl.
Prescribers will also have to provide the diagnosis or condition requiring the opioids when reporting through the state's controlled substances database, the Ohio Automated Rx Reporting System (OARRS).
Amol Soin, president of the state medical board and a pain management doctor, said the limits are reasonable and will reduce the amounts of unused prescription drugs in circulation.
On January 4, 2017, SB 319 was signed by Governor Kasich. This law (effective 4/6/2017) includes the following provisions as they relate to.